| |
Patents
RespireRx Pharmaceuticals has filed over 400 patents in the United States and offshore, which claim composition of matter, use, formulation, dosage and mechanism of action. Use claims include treating sleep apnea and preventing or rescuing drug-induced respiratory depression, as well as for improving memory and cognition, treating schizophrenia and other central nervous system indications. To date, 200 filings have issued or been allowed, with a considerable number still being reviewed. |
|
